{"count": 10, "results": [{"_id": "34707860", "pmid": 34707860, "pmcid": "PMC8515492", "title": "Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril", "journal": "F1000Res", "authors": ["Oktaviono YH", "Ahmad HA", "Al Farabi MJ", "Gandi P", "Givani CL", "Lumeno ISP", "Azmi Y"], "date": "2021-01-11T00:00:00Z", "doi": "10.12688/f1000research.26395.1", "meta_date_publication": "2021", "meta_volume": "10", "meta_issue": "", "meta_pages": "15", "score": 50293.414, "text_hl": "Meanwhile, high-dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (100mM) had the highest migration effect, suggesting it may be preferable for promoting EPC migration in @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Oktaviono YH, Ahmad HA, Al Farabi MJ, Gandi P, Givani CL, Lumeno ISP, Azmi Y. Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril F1000Res. 2021;10():15. PMID: 34707860", "BibTeX": "@article{34707860, title={Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril}, author={Oktaviono YH and Ahmad HA and Al Farabi MJ and Gandi P and Givani CL and Lumeno ISP and Azmi Y}, journal={F1000Res}, volume={10}, pages={15}}"}}, {"_id": "14695037", "pmid": 14695037, "title": "Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus.", "journal": "Pharmacotherapy", "authors": ["McConnell KJ", "Humphries TL", "Raebel MA", "Merenich JA", "Clinical Pharmacy Cardiac Risk Service Study Group"], "date": "2003-12-01T00:00:00Z", "doi": "10.1592/phco.23.15.1564.31963", "meta_date_publication": "2003 Dec", "meta_volume": "23", "meta_issue": "12", "meta_pages": "1564-72", "score": 50065.566, "text_hl": "Clinical pharmacy specialist implementation of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ therapy in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ and @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@.", "citations": {"NLM": "McConnell KJ, Humphries TL, Raebel MA, Merenich JA, Clinical Pharmacy Cardiac Risk Service Study Group. Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus. Pharmacotherapy. 2003 Dec;23(12):1564-72. PMID: 14695037", "BibTeX": "@article{14695037, title={Clinical pharmacy specialist implementation of lisinopril therapy in patients with coronary artery disease and diabetes mellitus.}, author={McConnell KJ and Humphries TL and Raebel MA and Merenich JA and Clinical Pharmacy Cardiac Risk Service Study Group}, journal={Pharmacotherapy}, volume={23}, number={12}, pages={1564-72}}"}}, {"_id": "8837313", "pmid": 8837313, "title": "The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters.", "journal": "Thromb Res", "authors": ["Zehetgruber M", "Beckmann R", "Gabriel H", "Christ G", "Binder BR", "Huber K"], "date": "1996-07-15T00:00:00Z", "doi": "10.1016/0049-3848(96)00115-6", "meta_date_publication": "1996 Jul 15", "meta_volume": "83", "meta_issue": "2", "meta_pages": "143-52", "score": 50056.168, "text_hl": "Therefore the present study examines the relationship between @GENE_INS @GENE_3630 @@@insulin@@@ and @GENE_SERPINE1 @GENE_5054 @@@PAI-1@@@ plasma levels during intravenous @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ tolerance tests before and after administration with the @GENE_AP2B1 @GENE_163 @@@ACE@@@-inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in 12 male @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ @SPECIES_9606 @@@patients@@@ with angiographically proven @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ and borderline @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Zehetgruber M, Beckmann R, Gabriel H, Christ G, Binder BR, Huber K. The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters. Thromb Res. 1996 Jul 15;83(2):143-52. PMID: 8837313", "BibTeX": "@article{8837313, title={The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters.}, author={Zehetgruber M and Beckmann R and Gabriel H and Christ G and Binder BR and Huber K}, journal={Thromb Res}, volume={83}, number={2}, pages={143-52}}"}}, {"_id": "1850668", "pmid": 1850668, "title": "Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.", "journal": "Circulation", "authors": ["Brilla CG", "Janicki JS", "Weber KT"], "date": "1991-05-01T00:00:00Z", "doi": "10.1161/01.cir.83.5.1771", "meta_date_publication": "1991 May", "meta_volume": "83", "meta_issue": "5", "meta_pages": "1771-9", "score": 50054.395, "text_hl": "Cardioreparative effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @SPECIES_10116 @@@rats@@@ with genetic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@.", "citations": {"NLM": "Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation. 1991 May;83(5):1771-9. PMID: 1850668", "BibTeX": "@article{1850668, title={Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.}, author={Brilla CG and Janicki JS and Weber KT}, journal={Circulation}, volume={83}, number={5}, pages={1771-9}}"}}, {"_id": "7842454", "pmid": 7842454, "title": "Angiotensin II receptor binding following myocardial infarction in the rat.", "journal": "Cardiovasc Res", "authors": ["Sun Y", "Weber KT"], "date": "1994-11-01T00:00:00Z", "doi": "10.1093/cvr/28.11.1623", "meta_date_publication": "1994 Nov", "meta_volume": "28", "meta_issue": "11", "meta_pages": "1623-8", "score": 50050.29, "text_hl": "Five groups were studied: age and sex matched controls receiving this operative procedure without subsequent @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (sham operated); @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery@@@ ligation and @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@; @SPECIES_10116 @@@rats@@@ with @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery@@@ ligation and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (20 mg.kg-1.d-1 in drinking water); sham operated @SPECIES_10116 @@@rats@@@ receiving @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@; and unoperated @SPECIES_10116 @@@rats@@@ which served as controls to pericardiotomy. ", "citations": {"NLM": "Sun Y, Weber KT. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res. 1994 Nov;28(11):1623-8. PMID: 7842454", "BibTeX": "@article{7842454, title={Angiotensin II receptor binding following myocardial infarction in the rat.}, author={Sun Y and Weber KT}, journal={Cardiovasc Res}, volume={28}, number={11}, pages={1623-8}}"}}, {"_id": "1535655", "pmid": 1535655, "title": "Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition.", "journal": "J Hypertens Suppl", "authors": ["Tan LB", "Brilla C", "Weber KT"], "date": "1992-04-01T00:00:00Z", "doi": "10.1097/00004872-199204001-00007", "meta_date_publication": "1992 Apr", "meta_volume": "10", "meta_issue": "1", "meta_pages": "S31-4", "score": 50040.64, "text_hl": "In established genetic @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ in @SPECIES_10116 @@@rats@@@, sustained treatment with high-dose @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ normalizes the blood pressure, reverses @DISEASE_Hypertrophy_Left_Ventricular @DISEASE_MESH:D017379 @@@left ventricular hypertrophy@@@, reverses excessive interstitial and perivascular @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@fibrosis@@@ (and consequently the impaired compliance), and reverses excessive @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery medial thickening@@@ (thereby normalizing coronary vascular reserve). ", "citations": {"NLM": "Tan LB, Brilla C, Weber KT. Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition. J Hypertens Suppl. 1992 Apr;10(1):S31-4. PMID: 1535655", "BibTeX": "@article{1535655, title={Prevention of structural changes in the heart in hypertension by angiotensin converting enzyme inhibition.}, author={Tan LB and Brilla C and Weber KT}, journal={J Hypertens Suppl}, volume={10}, number={1}, pages={S31-4}}"}}, {"_id": "9243253", "pmid": 9243253, "title": "Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.", "journal": "Fundam Clin Pharmacol", "authors": ["Mulder P", "Compagnon P", "Devaux B", "Richard V", "Henry JP", "Elfertak L", "Wimart MC", "Thibout E", "Comoy E", "Macé B", "Thuillez C"], "date": "1997-01-01T00:00:00Z", "doi": "10.1111/j.1472-8206.1997.tb00189.x", "meta_date_publication": "1997", "meta_volume": "11", "meta_issue": "3", "meta_pages": "221-30", "score": 50040.27, "text_hl": "@SPECIES_10116 @@@Rats@@@ with @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@CHF@@@ (@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery ligation@@@) were treated with placebo or the @GENE_ACE @GENE_24310 @@@ACE@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (10 mg/kg/d) starting 7 days after ligation. ", "citations": {"NLM": "Mulder P, Compagnon P, Devaux B, Richard V, Henry JP, Elfertak L, Wimart MC, Thibout E, Comoy E, Macé B, Thuillez C. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition. Fundam Clin Pharmacol. 1997;11(3):221-30. PMID: 9243253", "BibTeX": "@article{9243253, title={Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.}, author={Mulder P and Compagnon P and Devaux B and Richard V and Henry JP and Elfertak L and Wimart MC and Thibout E and Comoy E and Macé B and Thuillez C}, journal={Fundam Clin Pharmacol}, volume={11}, number={3}, pages={221-30}}"}}, {"_id": "29551122", "pmid": 29551122, "title": "Glucose Monitoring Dermopathy.", "journal": "Skinmed", "authors": ["Heymann WR"], "date": "2018-02-01T00:00:00Z", "meta_date_publication": "2018", "meta_volume": "16", "meta_issue": "1", "meta_pages": "74-75", "score": 50038.98, "text_hl": "His medical history was remarkable for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes mellitus@@@, @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@, and a pacemaker. ", "citations": {"NLM": "Heymann WR. Glucose Monitoring Dermopathy. Skinmed. 2018;16(1):74-75. PMID: 29551122", "BibTeX": "@article{29551122, title={Glucose Monitoring Dermopathy.}, author={Heymann WR}, journal={Skinmed}, volume={16}, number={1}, pages={74-75}}"}}, {"_id": "10071256", "pmid": 10071256, "title": "Long-term morbidity and mortality trials with amlodipine.", "journal": "J Cardiovasc Pharmacol", "authors": ["Oparil S"], "date": "1999-01-01T00:00:00Z", "doi": "10.1097/00005344-199900002-00002", "meta_date_publication": "1999", "meta_volume": "33 Suppl 2", "meta_issue": "", "meta_pages": "S1-6", "score": 50038.66, "text_hl": "The ALLHAT trial compares the effects of standard diuretic treatment with three alternative treatments (@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, and @CHEMICAL_Doxazosin @CHEMICAL_MESH:D017292 @@@doxazosin@@@) on the incidence of fatal @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ (@<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@CAD@@@) and nonfatal @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (MI) in 40,000 @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Oparil S. Long-term morbidity and mortality trials with amlodipine. J Cardiovasc Pharmacol. 1999;33 Suppl 2():S1-6. PMID: 10071256", "BibTeX": "@article{10071256, title={Long-term morbidity and mortality trials with amlodipine.}, author={Oparil S}, journal={J Cardiovasc Pharmacol}, volume={33 Suppl 2}, pages={S1-6}}"}}, {"_id": "11002856", "pmid": 11002856, "title": "[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].", "journal": "Drugs", "authors": ["Oparil S", "Bakir SE"], "date": "2000-01-01T00:00:00Z", "meta_date_publication": "2000", "meta_volume": "59 Spec No 2", "meta_issue": "", "meta_pages": "25-37", "score": 50031.156, "text_hl": "The Antihypertensive and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@-Lowering Treatment to Prevent @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@Heart Attack@@@ Trial (ALLHAT) compares the effects of standard diuretic treatment with 3 alternatives (@CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, and @CHEMICAL_Doxazosin @CHEMICAL_MESH:D017292 @@@doxazosin@@@) on the incidence of fatal @<m>DISEASE_Coronary_Artery_Disease</m> @DISEASE_MESH:D003324 @@@coronary artery disease@@@ and nonfatal @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ in more than 42,000 @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with additional cardiovascular risk factors. ", "citations": {"NLM": "Oparil S, Bakir SE. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Drugs. 2000;59 Spec No 2():25-37. PMID: 11002856", "BibTeX": "@article{11002856, title={[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].}, author={Oparil S and Bakir SE}, journal={Drugs}, volume={59 Spec No 2}, pages={25-37}}"}}]}